Aurora Therapeutics is reinventing how personalized gene-editing medicines are developed and approved for patients with rare diseases. The company combines state-of-the-art CRISPR engineering with umbrella regulatory pathways and modular CMC frameworks that allow many mutation-specific therapies to move forward in parallel. Aurora’s approach addresses the fundamental economic and operational barriers that have historically prevented treatments for rare mutations, enabling CRISPR therapies to reach patients at population scale. For more information, visit http://auroratherapeutics.com.

Aurora Therapeutics

Org chart

Teams

Offices